News
Victoria Gray is the first person in the world to receive CRISPR, a gene-editing therapy for sickle cell disease created by ...
The FDA has granted orphan drug status to rilzabrutinib, an investigational therapy to prevent pain crises in sickle cell ...
A Falmouth teen, Jayden Wilsey, is the first to receive gene therapy to treat sickle cell at Boston Children's Hospital.
New gene therapy improves the life of 18-year-old with Sickle Cell Disease which affects 5,000 New Jersey residents living ...
1d
Zacks Investment Research on MSNSNY's Rilzabrutinib Wins 4th Orphan Drug Tag for Sickle Cell DiseaseSanofi SNY announced that the FDA has granted orphan drug designation to its investigational BTK inhibitor, rilzabrutinib, ...
Sickle Cell 5K Walk/Run is taking place Saturday, June 21 at Riverside Park on the near northwest side of Indianapolis.
Understand the essentials of blood donation with this guide on who can give and who can receive blood. Learn eligibility ...
3d
The Mirror US on MSNSymptoms of a blood disorder GP says 'hides in plain sight'A survey found that 75% of people would not be able to recognize the signs and symptoms of common blood disorders ...
Poster Presentation: Pharmacokinetics (PK), Pharmacodynamics (PD), and Safety of the Novel Oral Fetal Hemoglobin (HBF) Induer Pociredir in Healthy Adults in a Phase 1 study (PF1170 – Friday, June 13) ...
The Pediatric Emergency Medicine and Pediatric Hematology/Oncology divisions at the Medical University of South Carolina ...
The Pediatric Emergency Medicine and Pediatric Hematology/Oncology divisions at MUSC have joined forces to create and test an ...
Scientists are making new discoveries every day, but many of them fall under the radar. Some of these findings are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results